Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Integra LifeSciences Second Quarter 2025 Financial Results Call.
Integra Lifesciences Holdings Corp (IART)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 174,364,000 | $172,859,587 | 3.14% | ||
| 2. | Rubric Capital Management David Rosen | 7,353,934 | $90,232,770 | +59% | 1.36% |
| 3. | 52,201,000 | $51,744,241 | 2.48% | ||
| 4. | 34,005,000 | $33,752,106 | +29% | 1.13% | |
| 5. | Soleus Capital Guy Levy | 1,387,818 | $17,028,527 | +30% | 1.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.49 | 52,641 | $1,499,978.97 | 487,922 | 2024-05-23 | Filing | |
| $27.40 | 36,350 | $995,815.52 | 36,350 | 2024-05-21 | Filing | |
| $37.89 | 2,640 | $100,035.14 | 48,597 | 2023-06-01 | Filing | |
| $38.50 | 7,792 | $299,985.77 | 12,798 | 2023-06-01 | Filing | |
| $56.08 | 1,933 | $108,399.16 | 3,665 | 2019-03-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.60 | 4,070 | $100,101.65 | 59,511 | 2024-12-03 | Filing | |
| $24.16 | 1,700 | $41,063.50 | 56,182 | 2024-12-02 | Filing | |
| $21.58 | 1,191 | $25,700.83 | 36,088 | 2024-08-19 | Filing | |
| $36.59 | 8,348 | $305,491.72 | 49,893 | 2024-03-06 | Filing | |
| $44.46 | 1,177 | $52,329.42 | 23,458 | 2023-08-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,351,752 | $127,015,997 | 0% | |
| 2. | 7,578,293 | $92,985,655 | 0% | |
| 3. | 87,500,000 | $86,899,653 | 3.01% | |
| 4. | 86,161,000 | $85,676,344 | 1.16% | |
| 5. | Invesco Ltd.BOND | 50,175,000 | $49,547,813 | 0.01% |
News See All
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2025 Earnings Call Transcript
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2025 Earnings Call Transcript May 5, 2025Integra LifeSciences Holdings Corporation misses on earnings expectations.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2024 Earnings Call Transcript
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2024 Earnings Call Transcript February 25, 2025Integra LifeSciences Holdings Corporation beats earnings expectations.
Here’s Why Integra LifeSciences Holdings Corporation (IART) Fell in Q3
Invesco Distributors, Inc., an investment management firm, released its “Invesco Small Cap Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2024 Earnings Call Transcript
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2024 Earnings Call Transcript November 4, 2024Integra LifeSciences Holdings Corporation beats earnings expectations.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2024 Earnings Call Transcript
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2024 Earnings Call Transcript July 29, 2024Integra LifeSciences Holdings Corporation misses on earnings expectations.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2024 Earnings Call Transcript
Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $-0.04221 EPS, expectations were $0.55.
11 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold healthcare stocks to buy right now.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q4 2023 Earnings Call Transcript
Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $0.89 EPS, expectations were $0.9.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Integra LifeSciences’ Third Quarter 2023 Financial Results Conference Call.
Billionaire Hedge Funds
